Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HORIZON-HF: Istaroxime in Worsening Heart Failure
NCT00616161Phase 2Completed
- Sponsor
- Sigma-Tau
- Start
- Aug 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of istaroxime in heart failure (HF), sponsored by Sigma-Tau. Started Aug 2006; status: completed.
02
Drugs
istaroxime
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00616161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616161.